Across TCGA pan-cancer cohorts, ZNF385D-AS1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ZNF385D-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where ZNF385D-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF385D-AS1 is over-expressed in tumor.

LIHC and KIRC are the cancer types where ZNF385D-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF385D-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.305	<.001	4	view →
KIRC	Male	All	+0.025	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ZNF385D-AS1 RNA expression & survival · all ZNF385D-AS1 data types